| Dr Chih-chien Wei, DO | |
|
11511 Ne 10th St, Bellevue, WA 98004-8578 | |
| (425) 502-3000 | |
| Not Available |
| Full Name | Dr Chih-chien Wei |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 11511 Ne 10th St, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457525776 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | OP60293997 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Mason Medical Center | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
| Virginia Mason Medical Center | 9830002617 | 825 |
News Archive
Health care professionals now have a new way of accessing ultrasound training in a mobile and affordable manner using the DR Doppler Dynamic Ultrasonography Training System (DR Doppler), a training tool from SIMnext, LLC, a medical simulation research and development company based in Peoria, Ill.
Meridian announced today strong results for the second quarter of 2009, with this being the second consecutive quarter of exceptional revenue and earnings. These results will undoubtedly help Meridian and its parent company, Visionary Integration Professionals (VIP), end 2009 with an exceptional three-year compound annual growth rate (CAGR). Between 2008 and 2005, Meridian and VIP posted a CAGR of 72.8 percent.
Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will display its Xineos family of CMOS dynamic flat X-Ray detectors at the RSNA 2016 Technical Exhibition, November 27 to December 2, at McCormick Place in Chicago.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better on this end point.
The Substance Abuse and Mental Health Services Administration's (SAMHSA's) just-released 2003 National Survey on Drug Use and Health (NSDUH) reports the number of current ecstasy users decreased between 2002 and 2003, from 676,000 (0.3 percent) to 470,000 (0.2 percent).
› Verified 8 days ago
| Entity Name | Virginia Mason Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801851258 PECOS PAC ID: 9830002617 Enrollment ID: O20031107000383 |
News Archive
Health care professionals now have a new way of accessing ultrasound training in a mobile and affordable manner using the DR Doppler Dynamic Ultrasonography Training System (DR Doppler), a training tool from SIMnext, LLC, a medical simulation research and development company based in Peoria, Ill.
Meridian announced today strong results for the second quarter of 2009, with this being the second consecutive quarter of exceptional revenue and earnings. These results will undoubtedly help Meridian and its parent company, Visionary Integration Professionals (VIP), end 2009 with an exceptional three-year compound annual growth rate (CAGR). Between 2008 and 2005, Meridian and VIP posted a CAGR of 72.8 percent.
Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will display its Xineos family of CMOS dynamic flat X-Ray detectors at the RSNA 2016 Technical Exhibition, November 27 to December 2, at McCormick Place in Chicago.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better on this end point.
The Substance Abuse and Mental Health Services Administration's (SAMHSA's) just-released 2003 National Survey on Drug Use and Health (NSDUH) reports the number of current ecstasy users decreased between 2002 and 2003, from 676,000 (0.3 percent) to 470,000 (0.2 percent).
› Verified 8 days ago
| Entity Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Health care professionals now have a new way of accessing ultrasound training in a mobile and affordable manner using the DR Doppler Dynamic Ultrasonography Training System (DR Doppler), a training tool from SIMnext, LLC, a medical simulation research and development company based in Peoria, Ill.
Meridian announced today strong results for the second quarter of 2009, with this being the second consecutive quarter of exceptional revenue and earnings. These results will undoubtedly help Meridian and its parent company, Visionary Integration Professionals (VIP), end 2009 with an exceptional three-year compound annual growth rate (CAGR). Between 2008 and 2005, Meridian and VIP posted a CAGR of 72.8 percent.
Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will display its Xineos family of CMOS dynamic flat X-Ray detectors at the RSNA 2016 Technical Exhibition, November 27 to December 2, at McCormick Place in Chicago.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better on this end point.
The Substance Abuse and Mental Health Services Administration's (SAMHSA's) just-released 2003 National Survey on Drug Use and Health (NSDUH) reports the number of current ecstasy users decreased between 2002 and 2003, from 676,000 (0.3 percent) to 470,000 (0.2 percent).
› Verified 8 days ago
| Entity Name | Evergreen Emergency Services Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619912524 PECOS PAC ID: 4981694155 Enrollment ID: O20040518000743 |
News Archive
Health care professionals now have a new way of accessing ultrasound training in a mobile and affordable manner using the DR Doppler Dynamic Ultrasonography Training System (DR Doppler), a training tool from SIMnext, LLC, a medical simulation research and development company based in Peoria, Ill.
Meridian announced today strong results for the second quarter of 2009, with this being the second consecutive quarter of exceptional revenue and earnings. These results will undoubtedly help Meridian and its parent company, Visionary Integration Professionals (VIP), end 2009 with an exceptional three-year compound annual growth rate (CAGR). Between 2008 and 2005, Meridian and VIP posted a CAGR of 72.8 percent.
Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will display its Xineos family of CMOS dynamic flat X-Ray detectors at the RSNA 2016 Technical Exhibition, November 27 to December 2, at McCormick Place in Chicago.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better on this end point.
The Substance Abuse and Mental Health Services Administration's (SAMHSA's) just-released 2003 National Survey on Drug Use and Health (NSDUH) reports the number of current ecstasy users decreased between 2002 and 2003, from 676,000 (0.3 percent) to 470,000 (0.2 percent).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chih-chien Wei, DO 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 | Dr Chih-chien Wei, DO 11511 Ne 10th St, Bellevue, WA 98004-8578 Ph: (425) 502-3000 |
News Archive
Health care professionals now have a new way of accessing ultrasound training in a mobile and affordable manner using the DR Doppler Dynamic Ultrasonography Training System (DR Doppler), a training tool from SIMnext, LLC, a medical simulation research and development company based in Peoria, Ill.
Meridian announced today strong results for the second quarter of 2009, with this being the second consecutive quarter of exceptional revenue and earnings. These results will undoubtedly help Meridian and its parent company, Visionary Integration Professionals (VIP), end 2009 with an exceptional three-year compound annual growth rate (CAGR). Between 2008 and 2005, Meridian and VIP posted a CAGR of 72.8 percent.
Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will display its Xineos family of CMOS dynamic flat X-Ray detectors at the RSNA 2016 Technical Exhibition, November 27 to December 2, at McCormick Place in Chicago.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that in the treatment of dyslipidemia, surveyed cardiologists and primary care physicians (PCPs) now perceive AstraZeneca's Crestor's ability to reduce mortality comparable to Pfizer's Lipitor. This finding has changed from Decision Resources' 2009 analysis in which surveyed cardiologists viewed Lipitor as significantly better on this end point.
The Substance Abuse and Mental Health Services Administration's (SAMHSA's) just-released 2003 National Survey on Drug Use and Health (NSDUH) reports the number of current ecstasy users decreased between 2002 and 2003, from 676,000 (0.3 percent) to 470,000 (0.2 percent).
› Verified 8 days ago
Dr. Stephen I Tilghman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15325 Se 30th Pl Ste 200, Bellevue, WA 98007 Phone: 425-641-4451 Fax: 425-641-7640 | |
Salma F Gharib, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Stephen W Marshall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101 | |
Marcus A Trione, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101 | |
Dr. Lawrence Chu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5623 168th Pl Se, Bellevue, WA 98006 Phone: 425-746-3515 | |
Cory Heidelberger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759 | |
Dr. Benjamin Andrew Savitch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759 |